Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 4.780
-0.210 (-4.21%)
May 28, 2026, 11:09 AM HKT
Jacobio Pharmaceuticals Group Employees
Jacobio Pharmaceuticals Group had 67 employees as of December 31, 2025. The number of employees increased by 5 or 8.06% compared to the previous year.
Employees
67
Change
5
Growth
8.06%
Revenue / Employee
889.00K HKD
Profits / Employee
-2.42M HKD
Market Cap
3.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 67 | 5 | 8.06% |
| Jun 30, 2025 | 211 | - | - |
| Dec 31, 2024 | 62 | -239 | -79.40% |
| Dec 31, 2023 | 301 | -2 | -0.66% |
| Dec 31, 2022 | 303 | 41 | 15.65% |
| Dec 31, 2021 | 262 | 85 | 48.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Employee RankingsJacobio Pharmaceuticals Group News
- 2 months ago - Jacobio Pharmaceuticals Group Earnings release: H2 2025 - Filings
- 2 months ago - Jacobio Pharmaceuticals Group Annual report: H2 2025 - Filings
- 5 months ago - Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 - PRNewsWire
- 8 months ago - Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline - PRNewsWire
- 9 months ago - Jacobio Pharma Announces 2025 Interim Results - PRNewsWire
- 9 months ago - Jacobio Pharmaceuticals Group Quarterly report: H1 2025 - Filings
- 9 months ago - Jacobio Pharmaceuticals Group Earnings release: H1 2025 - Filings
- 11 months ago - Jacobio's IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted - PRNewsWire